Marvell Technology Group Ltd. (MRVL): One of Tech’s Most Unloved Growth Stocks

Page 1 of 2

The phrase, “catching a falling knife” is overused for bear arguments. Whenever a company’s stock price crashes and bargain hunters swoop in for the deals, investing threads are flooded with the adage. Of course, sometimes it’s appropriate, but largely it is a hyperbolic statement. For Marvell Technology Group Ltd. (NASDAQ:MRVL), the pall cast by being associated with the dying PC industry has left the company with a depressed market value that fails to accurately account for the direction of the company. While it may be unfortunate in the short term for the company’s shareholders, Marvell Technology Group Ltd. (NASDAQ:MRVL) presents an attractive buy opportunity for the far-sighted.

A history of doing just fine
Marvell Technology (MRVL)Investors and analysts sometimes seem to forget that being a technology company involves a constant cycle of innovation and irrelevance. It’s a fast-moving industry, and the successful players find ways over time of reinventing the company to address current and future trends. The death of the PC is a popular trope these days, and for good reason, but it has dragged down the value and image of perfectly good companies.

Of course, we can point to giants that fell behind in innovation — Microsoft Corporation (NASDAQ:MSFT), Hewlett-Packard Company (NYSE:HPQ), maybe Apple Inc. (NASDAQ:AAPL) in five years. The thing is, it is not inherently bad to have been a major player in a technology that is being eclipsed — as long as you keep moving forward. I believe that is what semiconductor maker Marvell Technology Group Ltd. (NASDAQ:MRVL) is doing, while the market values it as a retiring dinosaur.

This PC-ocalypse has been in the making for at least five years (if not 10). If Marvell was to die with the PC, it would make sense for its long-term earnings growth to decline. But, over the past five years, Marvell has grown roughly 10.6% on an annualized basis. On the ever-important cash-flow front, that five-year number goes to 13.6%. The company continued making money on its product lineup for as long as it could, and now that product cycle is shifting out and making room for the next. This creates a short-term earnings (and price) dip, before the next round begins.

What’s on tap
Admittedly, Marvell is coming off a tough year. On an annual basis, net income took a bath, sinking 50% to just $304 million. The top line wasn’t as devastating, with revenue down just 7% over the prior year. The company ended 2012 with a lawsuit loss to Carnegie Mellon University, which alleged that Marvell infringed upon two of the school’s patents. The judge ordered a $1.1 billion penalty, but analysts are quick to point out that Marvell’s manufacture, distribution, and sale of products in question takes place almost exclusively outside of the United States. Hedge fund guru David Einhorn strongly believes this fee will be reduced substantially, or eliminated all together.

Page 1 of 2

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The Oldest Money Managers

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

The Best B-Boy Movies

Most Awesome Hip Hop Documentaries

Foods That Stain Your Teeth

Richest Doctors in the World

The Best Movie Sountracks Ever

The Highest Grossing Musicals on Broadway

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!